MET-eiwit (C-His, mens)

MET

AUTS9, c-Met, DA11, DFNB97, HGFR, RCCP2

C-His

< 1.0 EU per μg of the protein as determined by the LAL method

1.Flow cytometric analysis of anti-c-MET CAR expression. 5e5 of anti-c-MET CAR-293 cells were stained with 100 μL of 1:50 dilution (2 μL stock solution in 100 μL FACS buffer) of PE-conjugated human HGFR Protein (Site-Specific PE Conjugation, ECD, His Tag, Cat. No. 10692-H86H-SP) and negative control protein. Non-transduced 293 cells were used as a control (left) . PE signal was used to evaluate the binding activity (QC tested) . 2.Binding activity of PE-conjugated c-MET protein to PBMC cells. PBMC cells were stained with FITC conjugated anti-CD3 antibody and PE-conjugated human HGFR Protein (Site-Specific PE Conjugation, ECD, His Tag, Cat. No. 10692-H86H-SP) and detected by flow cytometry. FITC signal was used to evaluate the content of CD3+ T cells in PBMCs. PE signal was used to evaluate the non-specific binding activity to PBMCs (QC tested) .

Met1-Thr932

The recombinant Human MET consists of AA Met1-Thr932 with a polyhistidine tag at the C-terminus. It has a predicted molecular mass of 105.1 kDa.

Human